Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,705 public trials 3,134 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View all 13 locations
View Trial Details
Recruiting

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

NCT06865651

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +15 more
Locations
  • Ziaderm Research LLC North Miami Beach, Florida, United States
  • Endeavor Health Glenview, Illinois, United States
  • Novartis Investigative Site Grenoble, France
  • Novartis Investigative Site Montpellier, France
View all 17 locations
View Trial Details
Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

NCT05010005

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

NCT04915248

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • A.O. Spedali Civili di Brescia - Ematologia Brescia, Italy
  • Istituto Scientifico San Raffaele, Unità Linfomi - Dipartimento Oncoematologia Milan, Italy
  • U.O. Ematologia AO di Padova Padova, Italy
  • Ematologia IRCCS Policlinico S. Matteo di Pavia Pavia, Italy
View all 18 locations
View Trial Details
Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Recruiting

Feasibility of The Health Integrated Nutrition and Kidney Wellness Program

NCT07518719

Conditions
Cardiovascular Disease, Cardiovascular Diseases, Chronic Disease, +12 more
Locations
  • UPMC Kidney Clinic - Wexford Pittsburgh, Pennsylvania, United States
  • UPMC Kidney Clinic - Monroeville Pittsburgh, Pennsylvania, United States
  • UPMC Kidney Clinic - Oakland Pittsburgh, Pennsylvania, United States
  • UPMC Matilda H. Theiss Health Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NCT07166094

Conditions
Disease Attributes, Endometrial Cancer, Endometrial Neoplasms, +15 more
Locations
  • HonorHealth Research Inst Phoenix, Arizona, United States
  • Kaiser Permanente SoCal Irvine, California, United States
  • MedStar Washington Hospital Washington D.C., District of Columbia, United States
  • SMH - Sarasota - Main Campus Sarasota, Florida, United States
View all 171 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants

NCT07005713

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions